Taichung, Taiwan

Mei-Chih Chen

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Mei-Chih Chen

Introduction

Mei-Chih Chen is a prominent inventor based in Taichung, Taiwan. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies. With a total of six patents to his name, his work focuses on enhancing immune responses and treating various diseases.

Latest Patents

One of his latest patents is titled "Anti-specific antibody and nucleic acid encoding sequence thereof, and uses of the same." This patent provides an anti-specific antibody and the nucleic acid encoding sequence, which has shown effectiveness in treating infections and enhancing immune cells through various efficacy experiments. Another notable patent is "Fusion protein and nucleic acid encoding sequence thereof, and uses of the same." This invention presents a fusion protein that aids in treating cancer, immunoregulation, and activating immune cells, demonstrating promising results in efficacy experiments.

Career Highlights

Mei-Chih Chen has worked with reputable institutions, including China Medical University Hospital and Shine-On Biomedical Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Some of his notable coworkers include Der-Yang Cho and Shao-Chih Chiu, who have collaborated with him on various projects, enhancing the impact of their research.

Conclusion

Mei-Chih Chen's innovative work in the field of biomedical research has led to the development of important therapies that have the potential to improve patient outcomes. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…